Buckland hi.
Canine has clearly not been the focus because it’s dwarfed in value by other opportunities, and we have a very small team.
The trial can’t start until we have $. So mgmt are clearly delaying, and hoping ODD and some non dilutive contributors ,which MT has talked about before, come to fruition. Then they know how much to raise. So the start date is outside of PAA control.
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1214
-
- There are more pages in this discussion • 211 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.020(8.89%) |
Mkt cap ! $81.16M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 19.5¢ | $331.9K | 1.617M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 440882 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 12736 | 3 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |